Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Susan M. Duty, D.S.

TitleVisiting Scientist
InstitutionHarvard School of Public Health
DepartmentEH - Environmental + Occupational Medicine + Epi
AddressHarvard School of Public Health
Bldg 1, 14th Flr/Rm. 1420
665 Huntington Ave
Boston MA 02115
Phone617/432-6460

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Paul J, Jordan R, Duty S, Engstrom JL. Improving satisfaction with care and reducing length of stay in an obstetric triage unit using a nurse-midwife-managed model of care. J Midwifery Womens Health. 2013 Mar; 58(2):175-81.
    View in: PubMed
  2. Duty SM, Mendonca K, Hauser R, Calafat AM, Ye X, Meeker JD, Ackerman R, Cullinane J, Faller J, Ringer S. Potential sources of bisphenol a in the neonatal intensive care unit. Pediatrics. 2013 Mar; 131(3):483-9.
    View in: PubMed
  3. Duty S. Targeting glutamate receptors to tackle the pathogenesis, clinical symptoms and levodopa-induced dyskinesia associated with Parkinson's disease. CNS Drugs. 2012 Dec; 26(12):1017-32.
    View in: PubMed
  4. Sleeman IJ, Boshoff EL, Duty S. Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Neuropharmacology. 2012 Dec; 63(7):1268-77.
    View in: PubMed
  5. Betts MJ, O'Neill MJ, Duty S. Allosteric modulation of the group III mGlu(4) receptor provides functional neuroprotection in the 6-hydroxydopamine rat model of Parkinson's disease. Br J Pharmacol. 2012 Aug; 166(8):2317-30.
    View in: PubMed
  6. Carbone M, Duty S, Rattray M. Riluzole neuroprotection in a Parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation. BMC Neurosci. 2012; 13:38.
    View in: PubMed
  7. Broadstock M, Austin PJ, Betts MJ, Duty S. Antiparkinsonian potential of targeting group III metabotropic glutamate receptor subtypes in the rodent substantia nigra pars reticulata. Br J Pharmacol. 2012 Feb; 165(4b):1034-45.
    View in: PubMed
  8. Carbone M, Duty S, Rattray M. Riluzole elevates GLT-1 activity and levels in striatal astrocytes. Neurochem Int. 2012 Jan; 60(1):31-8.
    View in: PubMed
  9. Duty S, Jenner P. Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease. Br J Pharmacol. 2011 Oct; 164(4):1357-91.
    View in: PubMed
  10. Duty S. Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease. Br J Pharmacol. 2010 Sep; 161(2):271-87.
    View in: PubMed
  11. Austin PJ, Betts MJ, Broadstock M, O'Neill MJ, Mitchell SN, Duty S. Symptomatic and neuroprotective effects following activation of nigral group III metabotropic glutamate receptors in rodent models of Parkinson's disease. Br J Pharmacol. 2010 Aug; 160(7):1741-53.
    View in: PubMed
  12. Loftus J, Duty S. Educating ethnic minority students for the nursing workforce: facilitators and barriers to success. J Natl Black Nurses Assoc. 2010 Jul; 21(1):7-16.
    View in: PubMed
  13. Scott E, Duty S, McCue K. A critical evaluation of methicillin-resistant Staphylococcus aureus and other bacteria of medical interest on commonly touched household surfaces in relation to household demographics. Am J Infect Control. 2009 Aug; 37(6):447-53.
    View in: PubMed
  14. Ye X, Pierik FH, Hauser R, Duty S, Angerer J, Park MM, Burdorf A, Hofman A, Jaddoe VW, Mackenbach JP, Steegers EA, Tiemeier H, Longnecker MP. Urinary metabolite concentrations of organophosphorous pesticides, bisphenol A, and phthalates among pregnant women in Rotterdam, the Netherlands: the Generation R study. Environ Res. 2008 Oct; 108(2):260-7.
    View in: PubMed
  15. Scott E, Duty S, Callahan M. A pilot study to isolate Staphylococcus aureus and methicillin-resistant S aureus from environmental surfaces in the home. Am J Infect Control. 2008 Aug; 36(6):458-60.
    View in: PubMed
  16. Kwapniewski R, Kozaczka S, Hauser R, Silva MJ, Calafat AM, Duty SM. Occupational exposure to dibutyl phthalate among manicurists. J Occup Environ Med. 2008 Jun; 50(6):705-11.
    View in: PubMed
  17. Macinnes N, Duty S. Group III metabotropic glutamate receptors act as hetero-receptors modulating evoked GABA release in the globus pallidus in vivo. Eur J Pharmacol. 2008 Feb 2; 580(1-2):95-9.
    View in: PubMed
  18. Hauser R, Meeker JD, Singh NP, Silva MJ, Ryan L, Duty S, Calafat AM. DNA damage in human sperm is related to urinary levels of phthalate monoester and oxidative metabolites. Hum Reprod. 2007 Mar; 22(3):688-95.
    View in: PubMed
  19. Hauser R, Meeker JD, Duty S, Silva MJ, Calafat AM. Altered semen quality in relation to urinary concentrations of phthalate monoester and oxidative metabolites. Epidemiology. 2006 Nov; 17(6):682-91.
    View in: PubMed
  20. Visanji NP, O'Neill MJ, Duty S. Nicotine, but neither the alpha4beta2 ligand RJR2403 nor an alpha7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle. Neuropharmacology. 2006 Sep; 51(3):506-16.
    View in: PubMed
  21. Duty SM, Ackerman RM, Calafat AM, Hauser R. Personal care product use predicts urinary concentrations of some phthalate monoesters. Environ Health Perspect. 2005 Nov; 113(11):1530-5.
    View in: PubMed
  22. Visanji NP, Mitchell SN, O'Neill MJ, Duty S. Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and alpha6 and beta3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat. Neuropharmacology. 2006 Jan; 50(1):36-46.
    View in: PubMed
  23. Duty SM, Calafat AM, Silva MJ, Ryan L, Hauser R. Phthalate exposure and reproductive hormones in adult men. Hum Reprod. 2005 Mar; 20(3):604-10.
    View in: PubMed
  24. Trisini AT, Singh NP, Duty SM, Hauser R. Relationship between human semen parameters and deoxyribonucleic acid damage assessed by the neutral comet assay. Fertil Steril. 2004 Dec; 82(6):1623-32.
    View in: PubMed
  25. Macinnes N, Duty S. Locomotor effects of imidazoline I2-site-specific ligands and monoamine oxidase inhibitors in rats with a unilateral 6-hydroxydopamine lesion of the nigrostriatal pathway. Br J Pharmacol. 2004 Dec; 143(8):952-9.
    View in: PubMed
  26. Meeker JD, Singh NP, Ryan L, Duty SM, Barr DB, Herrick RF, Bennett DH, Hauser R. Urinary levels of insecticide metabolites and DNA damage in human sperm. Hum Reprod. 2004 Nov; 19(11):2573-80.
    View in: PubMed
  27. Hauser R, Duty S, Godfrey-Bailey L, Calafat AM. Medications as a source of human exposure to phthalates. Environ Health Perspect. 2004 May; 112(6):751-3.
    View in: PubMed
  28. Duty SM, Calafat AM, Silva MJ, Brock JW, Ryan L, Chen Z, Overstreet J, Hauser R. The relationship between environmental exposure to phthalates and computer-aided sperm analysis motion parameters. J Androl. 2004 Mar-Apr; 25(2):293-302.
    View in: PubMed
  29. MacInnes N, Messenger MJ, Duty S. Activation of group III metabotropic glutamate receptors in selected regions of the basal ganglia alleviates akinesia in the reserpine-treated rat. Br J Pharmacol. 2004 Jan; 141(1):15-22.
    View in: PubMed
  30. Henry B, Duty S, Fox SH, Crossman AR, Brotchie JM. Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease. Exp Neurol. 2003 Oct; 183(2):458-68.
    View in: PubMed
  31. Johnston T, Duty S. GABA(B) receptor agonists reverse akinesia following intranigral or intracerebroventricular injection in the reserpine-treated rat. Br J Pharmacol. 2003 Aug; 139(8):1480-6.
    View in: PubMed
  32. Duty SM, Singh NP, Silva MJ, Barr DB, Brock JW, Ryan L, Herrick RF, Christiani DC, Hauser R. The relationship between environmental exposures to phthalates and DNA damage in human sperm using the neutral comet assay. Environ Health Perspect. 2003 Jul; 111(9):1164-9.
    View in: PubMed
  33. Duty SM, Silva MJ, Barr DB, Brock JW, Ryan L, Chen Z, Herrick RF, Christiani DC, Hauser R. Phthalate exposure and human semen parameters. Epidemiology. 2003 May; 14(3):269-77.
    View in: PubMed
  34. Johnston T, Duty S. Changes in GABA(B) receptor mRNA expression in the rodent basal ganglia and thalamus following lesion of the nigrostriatal pathway. Neuroscience. 2003; 120(4):1027-35.
    View in: PubMed
  35. Murray TK, Messenger MJ, Ward MA, Woodhouse S, Osborne DJ, Duty S, O'Neill MJ. Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's disease. Pharmacol Biochem Behav. 2002 Sep; 73(2):455-66.
    View in: PubMed
  36. O'Neill MJ, Murray TK, Lakics V, Visanji NP, Duty S. The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration. Curr Drug Targets CNS Neurol Disord. 2002 Aug; 1(4):399-411.
    View in: PubMed
  37. Messenger MJ, Dawson LG, Duty S. Changes in metabotropic glutamate receptor 1-8 gene expression in the rodent basal ganglia motor loop following lesion of the nigrostriatal tract. Neuropharmacology. 2002 Aug; 43(2):261-71.
    View in: PubMed
  38. Duty SM, Singh NP, Ryan L, Chen Z, Lewis C, Huang T, Hauser R. Reliability of the comet assay in cryopreserved human sperm. Hum Reprod. 2002 May; 17(5):1274-80.
    View in: PubMed
  39. Chadha A, Sur C, Atack J, Duty S. The 5HT(1B) receptor agonist, CP-93129, inhibits [(3)H]-GABA release from rat globus pallidus slices and reverses akinesia following intrapallidal injection in the reserpine-treated rat. Br J Pharmacol. 2000 Aug; 130(8):1927-32.
    View in: PubMed
  40. Chadha A, Howell O, Atack JR, Sur C, Duty S. Changes in [3H]zolpidem and [3H]Ro 15-1788 binding in rat globus pallidus and substantia nigra pars reticulata following a nigrostriatal tract lesion. Brain Res. 2000 Apr 17; 862(1-2):280-3.
    View in: PubMed
  41. Dawson L, Chadha A, Megalou M, Duty S. The group II metabotropic glutamate receptor agonist, DCG-IV, alleviates akinesia following intranigral or intraventricular administration in the reserpine-treated rat. Br J Pharmacol. 2000 Feb; 129(3):541-6.
    View in: PubMed
  42. Chadha A, Dawson LG, Jenner PG, Duty S. Effect of unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway on GABA(A) receptor subunit gene expression in the rodent basal ganglia and thalamus. Neuroscience. 2000; 95(1):119-26.
    View in: PubMed
  43. Duty S, Henry B, Crossman AR, Brotchie JM. Topographical organization of opioid peptide precursor gene expression following repeated apomorphine treatment in the 6-hydroxydopamine-lesioned rat. Exp Neurol. 1998 Apr; 150(2):223-34.
    View in: PubMed
  44. Duty S, Brotchie JM. Enhancement of the behavioral response to apomorphine administration following repeated treatment in the 6-hydroxydopamine-lesioned rat is temporally correlated with a rise in striatal preproenkephalin-B, but not preproenkephalin-A, gene expression. Exp Neurol. 1997 Apr; 144(2):423-32.
    View in: PubMed
  45. Maneuf YP, Duty S, Hille CJ, Crossman AR, Brotchie JM. Modulation of GABA transmission by diazoxide and cromakalim in the globus pallidus: implications for the treatment of Parkinson's disease. Exp Neurol. 1996 May; 139(1):12-6.
    View in: PubMed
  46. Duty S, Allen DG. The effects of glibenclamide on tetanic force and intracellular calcium in normal and fatigued mouse skeletal muscle. Exp Physiol. 1995 Jul; 80(4):529-41.
    View in: PubMed
  47. Duty S, Allen DG. The distribution of intracellular calcium concentration in isolated single fibres of mouse skeletal muscle during fatiguing stimulation. Pflugers Arch. 1994 May; 427(1-2):102-9.
    View in: PubMed
  48. Allen D, Duty S, Westerblad H. Examined the activation of central myofibrils during muscle fatigue caused by repeated short tetani. J Muscle Res Cell Motil. 1993 Oct; 14(5):543-5.
    View in: PubMed
  49. Westerblad H, Duty S, Allen DG. Intracellular calcium concentration during low-frequency fatigue in isolated single fibers of mouse skeletal muscle. J Appl Physiol. 1993 Jul; 75(1):382-8.
    View in: PubMed
  50. Brotchie J, Crossman A, Mitchell I, Duty S, Carroll C, Cooper A, Henry B, Hughes N, Maneuf Y. Chemical signalling in the globus pallidus in parkinsonism. Prog Brain Res. 1993; 99:125-39.
    View in: PubMed
  51. Duty S, Weston AH. Characteristics of the contractile response of rabbit aorta produced by cromakalim in calcium-free solution. Br J Pharmacol. 1992 Dec; 107(4):1198-204.
    View in: PubMed
  52. Bray KM, Weston AH, Duty S, Newgreen DT, Longmore J, Edwards G, Brown TJ. Differences between the effects of cromakalim and nifedipine on agonist-induced responses in rabbit aorta. Br J Pharmacol. 1991 Feb; 102(2):337-44.
    View in: PubMed
  53. Duty S, Weston AH. Potassium channel openers. Pharmacological effects and future uses. Drugs. 1990 Dec; 40(6):785-91.
    View in: PubMed
  54. Duty S, Paciorek PM, Waterfall JF, Weston AH. A comparison of the haemodynamic profiles of Ro 31-6930, cromakalim and nifedipine in anaesthetised normotensive rats. Eur J Pharmacol. 1990 Aug 21; 185(1):35-42.
    View in: PubMed
  55. Newgreen DT, Bray KM, McHarg AD, Weston AH, Duty S, Brown BS, Kay PB, Edwards G, Longmore J, Southerton JS. The action of diazoxide and minoxidil sulphate on rat blood vessels: a comparison with cromakalim. Br J Pharmacol. 1990 Jul; 100(3):605-13.
    View in: PubMed
  56. Weston AH, Longmore J, Newgreen DT, Edwards G, Bray KM, Duty S. The potassium channel openers: a new class of vasorelaxants. Blood Vessels. 1990; 27(2-5):306-13.
    View in: PubMed
  57. Bray KM, Duty S, Weston AH. Effects of glibenclamide on cromakalim-induced responses in rabbit isolated aorta. Br J Pharmacol. 1989 Dec; 98 Suppl:806P.
    View in: PubMed
  58. Small RC, Boyle JP, Duty S, Elliott KR, Foster RW, Watt AJ. Analysis of the relaxant effects of AH 21-132 in guinea-pig isolated trachealis. Br J Pharmacol. 1989 Aug; 97(4):1165-73.
    View in: PubMed
  59. Duty S, Weston AH. The biochemical regulation of potassium channels. Biochem Soc Trans. 1988 Aug; 16(4):532-4.
    View in: PubMed
  60. Weston AH, Bray KM, Duty S, McHarg AD, Newgreen DT, Southerton JS. In vitro studies on the mode of action of pinacidil. Drugs. 1988; 36 Suppl 7:10-28.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Justin Sayde (jsaydehsph.harvard.edu).
Duty's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_